Europe Rare Biomarkers Specimen Collection And Stabilization Market Size & Outlook
Europe rare biomarkers specimen collection and stabilization market, 2018-2030 (US$M)
Related Markets
Europe rare biomarkers specimen collection and stabilization market highlights
- The Europe rare biomarkers specimen collection and stabilization market generated a revenue of USD 11,722.8 million in 2023.
- The market is expected to grow at a CAGR of 12.2% from 2024 to 2030.
- In terms of segment, circulating cell free dna (ccfdna) was the largest revenue generating biomarker in 2023.
- Circulating Cell Free DNA (ccfDNA) is the most lucrative biomarker segment registering the fastest growth during the forecast period.
Europe data book summary
| Market revenue in 2023 | USD 11,722.8 million |
| Market revenue in 2030 | USD 26,207.0 million |
| Growth rate | 12.2% (CAGR from 2023 to 2030) |
| Largest segment | Circulating cell free dna (ccfdna) |
| Fastest growing segment | Circulating Cell Free DNA (ccfDNA) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Circulating Cell Free DNA (ccfDNA) |
| Key market players worldwide | Qiagen NV, Charles River Laboratories International Inc, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Eurofins Scientific SE, PerkinElmer, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Merck KGaA, Siemens Healthineers AG ADR |
Other key industry trends
- In terms of revenue, Europe region accounted for 31.1% of the global rare biomarkers specimen collection and stabilization market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 12,677.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rare Biomarkers Specimen Collection And Stabilization Market Scope
Rare Biomarkers Specimen Collection And Stabilization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe rare biomarkers specimen collection and stabilization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rare biomarkers specimen collection and stabilization market will help companies and investors design strategic landscapes.
Circulating cell free dna (ccfdna) was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe rare biomarkers specimen collection and stabilization market based on circulating cell free dna (ccfdna) covering the revenue growth of each sub-segment from 2018 to 2030.
Rapidly growing interest in cell-free circulating biomarkers for disease management is expected to positively impact the Europe market in the coming years. In January 2018, Aruna Biomedical launched a new class of cell-free exosome biologics for the treatment of neurodegenerative and central nervous system disorders.
Launch of cell free biomarkerbased products, including diagnostics and therapeutics, has driven the uptake of biomarker isolation kits. In addition, collaborations between companies, including domestic as well as global companies, to boost R&D in personalized therapy and cancer diagnostics are expected to aid the revenue growth in this regional market.
Reasons to subscribe to Europe rare biomarkers specimen collection and stabilization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe rare biomarkers specimen collection and stabilization market databook
-
Our clientele includes a mix of rare biomarkers specimen collection and stabilization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe rare biomarkers specimen collection and stabilization market , including forecasts for subscribers. This continent databook contains high-level insights into Europe rare biomarkers specimen collection and stabilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe rare biomarkers specimen collection and stabilization market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
